Toxoplasma chorioretinitis
ICD-10 B57.4 is a billable code used to indicate a diagnosis of toxoplasma chorioretinitis.
Toxoplasma chorioretinitis is an ocular manifestation of Toxoplasma gondii infection, a protozoan parasite that can cause severe complications in immunocompromised individuals, particularly those with HIV/AIDS. The condition is characterized by inflammation of the choroid and retina, leading to symptoms such as blurred vision, floaters, and in severe cases, vision loss. Toxoplasmosis is often acquired through ingestion of oocysts from contaminated food or water, or through vertical transmission from mother to fetus during pregnancy. Diagnosis typically involves clinical examination, serological testing for Toxoplasma antibodies, and imaging studies such as fundus photography or optical coherence tomography. Treatment usually includes the use of pyrimethamine and sulfadiazine, along with leucovorin to mitigate bone marrow suppression. Early diagnosis and treatment are crucial to prevent irreversible damage to the retina and preserve vision.
Detailed ocular examination findings, including visual acuity and fundoscopic findings.
Patients presenting with blurred vision and floaters, particularly in immunocompromised individuals.
Ensure documentation reflects the severity of the condition and any associated systemic symptoms.
Comprehensive history of exposure, serological test results, and treatment plans.
Patients with HIV/AIDS presenting with ocular symptoms and a history of Toxoplasma exposure.
Document any co-infections and the patient's immune status to support the diagnosis.
Used during initial evaluation of a patient suspected of having Toxoplasma chorioretinitis.
Document visual acuity, fundoscopic findings, and any relevant history.
Ophthalmologists should ensure comprehensive documentation of ocular findings.
Common symptoms include blurred vision, floaters, and in severe cases, vision loss. Patients may also experience eye pain and redness.
